Please login to the form below

Not currently logged in
Email:
Password:

Abbott

This page shows the latest Abbott news and features for those working in and with pharma, biotech and healthcare.

In sickness and in health

In sickness and in health

see patient versions of Abbott’s i-STAT device. Out of the home, innovations like Philip’s Ingenia are enabling early cancer detection by integrating MRI and CT scans, which of ... Abbott’s work, encouraging diabetes patients to be proactive in

Latest news

  • Healthineers’ COVID-19 antibody test launches in EU Healthineers’ COVID-19 antibody test launches in EU

    Aside from the COV2T test, the researchers evaluated Abbott’s SARS-CoV-2 Immunoassay, DiaSorin’s LIAISON SARSCoV-2 S1/S2 IgG and Roche’s Elecsys Anti-SARS-CoV-2. ... The Healthineers test came out on top, with a sensitivity value of 98.1% and a

  • Healthineers’ COVID-19 antibody test proves most effective in comparative study Healthineers’ COVID-19 antibody test proves most effective in comparative study

    Beats tests from Roche, Abbott and DiaSorin. In a comparative study conducted by Public Health England in partnership with Oxford University, Siemens Healthineers’ COVID-19 antibody test proved the most effective ... That included Abbott’s SARS-CoV-2

  • Key emerging trends in digital health Key emerging trends in digital health

    An exciting development for those living with type 1 diabetes comes from Abbott, a glucose sensing technology company, and Insulet, a diabetes medical device company, who have partnered to develop integrated ... Abbott’s continuous glucose monitoring

  • J&J says COVID-19 vaccine could be ready in early 2021 J&J says COVID-19 vaccine could be ready in early 2021

    New point-of-care diagnostic approved. There has also been encouraging news from another US corporation – Abbott – which is launching a rapid test for COVID-19 next week that uses a ... The kit sits alongside Abbott’s lab-based COVID-19 diagnostic,

  • Boris Johnson pledges fast-track visas for key NHS workers Boris Johnson pledges fast-track visas for key NHS workers

    However, shadow home secretary Diane Abbott accused the Conservatives of using “dog whistle anti-migrant rhetoric but are forced to accept we need migrant workers for key sectors, not just the

More from news
Approximately 12 fully matching, plus 289 partially matching documents found.

Latest Intelligence

  • Back to the future Back to the future

    Even in 2016 we could see it with Abbott/Abbvie and Sandoz/ Novartis and the years since then have seen that trend amplified.

  • Adding value in emerging markets Adding value in emerging markets

    is executive vice president of Established Pharmaceuticals, Abbott's branded-generic business. 15th November 2017.

  • Deal Watch - May 2017 Deal Watch - May 2017

    due diligence had identified the issues Abbott had chosen to sign the deal. ... 710 (upfront 310). Alere (US). Abbott (US). Acquisition settlement. Reduction in acquisition price from $5.5bn to $5bn.

  • Deal Watch October 2016 Deal Watch October 2016

    This month there were two more deals of this type. The disposal by Abbott to Terumo of some vascular closure products for $1.1bn triggered by Abbott's intended takeover of ... 1, 404. Abbott &St Jude (US). Terumo (JP). Asset Acquisition. Vascular closure

  • Deal Watch September 2016 Deal Watch September 2016

    Abbott, Allergan, Celgene, Moderna, Pfizer and Takeda feature in this month's pharma deals round-up. ... Abbott Medical Optics / J&J. Acquisition corporate. J&J acquisition of Abbott Medical Optics.

More from intelligence
Approximately 1 fully matching, plus 30 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 41 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 11 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....